← SynDRA
TELBIVUDINE
SynDRA canonical compound SYN0006484 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | DNA polymerase inhibitor |
|---|
| Indication | hepatitis B |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- DNA polymerase inhibitor
- Inhibitor
- P INHIBITOR
Drug classes
- Nucleoside Reverse Transcriptase Inhibitors
- Anti-Infective Agents
- Antiviral Agents
- Enzyme Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- sebivo
- beta-L-Thymidine
- epavudine
- L-Thymidine
- Telbivudina
- 2'-deoxy-l-thymidine
- LDT-600
- LDT600
- NV-02B
- Sebivo
- Tyzeka
- Epavudine
- LLT
- LdT
- Telbivudin
- Telbivudine [USAN]
- NB 02B
- L-Deoxythymidine
- L-dT
- Tyzeka (TN)
- Beta-L-Thymidine
- Telbivudine (USAN/INN)
- Tyzake/Sebivo (TN)
- Tyzeka, Sebivo, Telbivudine
- 1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione
- 1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione
- 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
- 2'-Deoxy-L-thymidine
- NV 02B
- beta L 2' Deoxythymidine
- 2OC4HKD3SF
- CHEBI:63624
- 1-(2-deoxy-beta-L-ribofuranosyl)-5-methyluracil
- telbivudinum
- RefChem:57765
- DTXCID90110304
- J05AF11
- MFCD02683612
Look up TELBIVUDINE in the interactive SynDRA portal →